International Journal of Risk & Safety in Medicine · 2020 · 35 citations · 13 references
Veterinary MedicineImmunologyInfectious DiseasesImmunizationVaccinologyVirologyAntiviral TherapyTreatmentVaccinationVaccine-preventable DiseasesViral InfectionsViral VaccinesAntibodiesCoronavirus Infection ControlCoronavirus Infection PreventionCoronavirus VaccinesSars-cov-2 Antiviral TherapySars-cov-2 InfectionTreatment Of Coronavirus Infections
The ongoing COVID-19 pandemic has infected nearly 3,582,233 individuals with 248,558 deaths since it was first identified in human populations in December 2019 in Wuhan, China. No antiviral therapies or vaccines are available for their treatment or prevention. Passive immunization PI through broadly neutralizing antibodies that bind to the specific antigens of SARS-CoV 2 might be a potential solution to address the immediate health threat of COVID-19 pandemic while vaccines are being developed. The PI approach in treating COVID-19 is discussed herein, including a summary of its historical applications to confront epidemics.
13
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Xing-Yi Ge, Jialu Li, Xing‐Lou Yang et al. · Nature · 2013 · 1.9K citations · Full text
Clinical characteristics of 2019 novel coronavirus infection in China
Wei‐jie Guan, Zhengyi Ni, Yu Hu et al. · medRxiv · 2020 · 1.5K citations · Full text
Veterinary Medicine, Infectious Diseases, Emerging Infectious Diseases +9